Viewing Study With Definitions



Ignite Creation Date: 2024-05-06 @ 12:24 AM
Last Modification Date: 2024-10-26 @ 10:49 AM
Study NCT ID: NCT01561911
Status: COMPLETED
Last Update Posted: 2014-12-02
First Post: 2012-03-21

Brief Title: A Phase I Study of the Chimeric Anti-CD40 Monoclonal Antibody ChiLob 74 to Treat Advanced Malignancies Refractory to Conventional Anti-cancer Treatment
Sponsor:
Organization: Cancer Research UK